Reprinted from Poz.com (link below) I read Regan Hofmann’s blog-post last week titled “Not Drinking the PrEP Kool-AIDS” with a mixture of dread (would I be accused of being an irresponsible PrEP cheerleader?) and a growing sense of déjà vu. By the end of the piece…Read More
Category Archives: HIV prevention
July 15, 2011
Project Inform urges government action following the positive results of two PrEP studies in heterosexual men and women
San Francisco, CA — Two new studies of pre-exposure prophylaxis (PrEP) in heterosexuals in Africa have demonstrated that the antiretroviral (ARV) Viread (tenofovir) or Truvada (tenofovir plus emtracitabine), taken by HIV-negative people, substantially reduces the number of new HIV infections. “The success of these new studies—when…Read More
by Meredith Mazzotta, Center for Global Health Policy Investigators at the HIV Prevention Trials Network (HPTN) Annual Meeting Monday received an update on a study looking to ease the pill burden on those wishing to benefit from pre-exposure prophylaxis (PrEP). Inspired by studies of non-human primates…Read More
Read the REPORT. The iPrEx study considered whether taking the drug Truvada on a daily basis, in combination with safe sex counseling, could prevent gay and bisexual men from becoming infected with HIV. In November, the study reported that Pre-Exposure Prophylaxis, or PrEP, could be as…Read More
May 12, 2011
Disappointing early results halt women’s PrEP study
April 22, 2011 On April 18, 2011, researchers stopped a study that used a daily pill to prevent HIV infection in heterosexual women. Early results from the study, called FEM PrEP, revealed it could not show that Truvada would work in this study population. The researchers cautioned…Read More
April 20, 2011 The iPrEx study, conducted among 2,499 gay and bisexual men and female transgenders at high risk for HIV-infection in the US, South Africa, South America and Thailand, reported extremely hopeful results about the effectiveness of taking the antiretroviral Truvada daily in combination with…Read More
March 21, 2011
Prevention study failed in one respect, but increases our understanding of transmission
March 22, 2011 From CROI, March 2011: A large African study (Partners in Prevention) that tried to prevent HIV by using aciclovir to prevent herpes infections failed to show any effect on reducing HIV transmissions, as reported last year at CROI. This year, however, three new…Read More